Changes in multi-modality management of acromegaly in a tertiary centre over 2 decades

V. Amodru, N. Sahakian, C. Piazzola, R. Appay, T. Graillon, T. Cuny, I. Morange, F. Albarel, M. Vermalle, J. Regis, H. Dufour, T. Brue,F. Castinetti

Pituitary(2024)

引用 0|浏览0
暂无评分
摘要
Acromegaly is a rare disease associated with chronic multisystem complications. New therapeutic strategies have emerged in the last decades, combining pituitary transsphenoidal surgery (TSS), radiotherapy or radiosurgery (RXT) and medical treatments. This retrospective monocentric study focused on presentation, management and outcome of acromegaly patients diagnosed between 2000 and 2020, still followed up in 2020, with a minimum follow-up of 1 year, and comparison of the first vs. second decade of the study. 275 patients were included, 50 diagnosed before 2010 and 225 after 2010. 95
更多
查看译文
关键词
Acromegaly,Pituitary neuroendocrine tumor (PitNET),Octreotide,Lanreotide,Pegvisomant,Pasireotide
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要